CRDA - Ticker AI Digest

Croda International PLC 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (CRDA) 1
CRDA 10:29
Croda International PLC
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of shares under the Companys Share Incentive Plan by the SIP Trustee (Equiniti Share Plan Trustees Limited) - partnership shares purchased on behalf of PDMRs as detailed in c) and matching shares awarded to PDMRs as detailed in c).
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 3
CRDA 10:29
Croda International PLC
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of shares under the Companys Share Incentive Plan by the SIP Trustee (Equiniti Share Plan Trustees Limited) - partnership shares purchased on behalf of PDMRs as detailed in c) and matching shares awarded to PDMRs as detailed in c).
CRDA 12:33
Croda International PLC
Director/PDMR Shareholding
CRDA 14:00
Croda International PLC
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of shares under the Companys Share Incentive Plan by the SIP Trustee (Equiniti Share Plan Trustees Limited) - partnership shares purchased on behalf of PDMRs as detailed in c) and matching shares awarded to PDMRs as detailed in c).
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
CRDA 06:01
Croda International PLC
Results for the year ended 31 December 2025
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Croda International PLCs Final Results for the Year Ended 31 December 2025**
Croda International PLC, a leading specialty chemicals company, announced its final results for the year ended 31 December 2025, highlighting encouraging progress in delivering its growth and returns strategy despite an uncertain trading environment.
**Financial Highlights**
**Sales Growth** Group sales increased by 4.4% to £1,699.4 million, with a 6.6% growth at constant currency. Consumer Care and Life Sciences segments led the growth, with sales up 8% in both segments.
**Adjusted Operating Profit** Adjusted operating profit rose by 7.9% to £295.3 million at constant currency, driven by improved profitability in Consumer Care and Life Sciences.
**Adjusted Profit Before Tax** Adjusted profit before tax increased by 8.4% to £276.2 million, or £282.0 million at constant currency.
**Dividend** The full-year dividend was increased by 1p to 111p per share.
**Business Performance**
**Consumer Care** Sales grew by 8% at constant currency, with strong performance in Fragrances and Flavours (F&F), Beauty Actives, and Beauty Care.
**Life Sciences** Sales increased by 8% at constant currency, driven by growth in Crop Protection and Pharma.
**Industrial Specialties** Sales declined by 2% at constant currency due to lower sales volumes.
**Strategic Progress**
**Innovation** Croda refocused its innovation efforts, introducing a new rigorous framework and reallocating R&D resources to prioritize customer-centric innovation.
**Customer Experience** The company improved customer experience through tailored solutions, bespoke service packages, and regionalization of claims testing and formulation support.
**Transformation Program** Crodas transformation program delivered £28 million in gross benefits in 2025, with a target of £100 million in total annualized benefits by 2028.
**Financial Framework to 2028**
Croda set out a new financial framework to 2028, targeting
**Sales Growth** 3-6% organic sales growth CAGR
**Adjusted Operating Margin** >20% by 2028
**Free Cash Flow-to-Sales Ratio** >12% by 2028
**Return on Invested Capital (ROIC)** >10% by 2028
**2026 Outlook**
For 2026Croda expects
**Group Organic Sales Growth** Within the 3-6% range
**Adjusted Operating Margin** Further increase driven by improving profitability in Consumer Care and Life Sciences
**Adjusted Operating Profit** In line with current market expectations at constant currency
**Conclusion**
Croda International PLC demonstrated resilience and progress in 2025, delivering sales growth, improved profitability, and strategic advancements despite market challenges. The companys financial framework to 2028 and 2026 outlook reflect its confidence in achieving sustainable growth, enhanced profitability, and improved returns on capital.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 1
CRDA 16:14
Croda International PLC
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 5
CRDA 10:29
Croda International PLC
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of shares under the Companys Share Incentive Plan by the SIP Trustee (Equiniti Share Plan Trustees Limited) - partnership shares purchased on behalf of PDMRs as detailed in c) and matching shares awarded to PDMRs as detailed in c).
CRDA 12:33
Croda International PLC
Director/PDMR Shareholding
CRDA 16:14
Croda International PLC
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
CRDA 06:01
Croda International PLC
Results for the year ended 31 December 2025
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Croda International PLCs Final Results for the Year Ended 31 December 2025**
Croda International PLC, a leading specialty chemicals company, announced its final results for the year ended 31 December 2025, highlighting encouraging progress in delivering its growth and returns strategy despite an uncertain trading environment.
**Financial Highlights**
**Sales Growth** Group sales increased by 4.4% to £1,699.4 million, with a 6.6% growth at constant currency. Consumer Care and Life Sciences segments led the growth, with sales up 8% in both segments.
**Adjusted Operating Profit** Adjusted operating profit rose by 7.9% to £295.3 million at constant currency, driven by improved profitability in Consumer Care and Life Sciences.
**Adjusted Profit Before Tax** Adjusted profit before tax increased by 8.4% to £276.2 million, or £282.0 million at constant currency.
**Dividend** The full-year dividend was increased by 1p to 111p per share.
**Business Performance**
**Consumer Care** Sales grew by 8% at constant currency, with strong performance in Fragrances and Flavours (F&F), Beauty Actives, and Beauty Care.
**Life Sciences** Sales increased by 8% at constant currency, driven by growth in Crop Protection and Pharma.
**Industrial Specialties** Sales declined by 2% at constant currency due to lower sales volumes.
**Strategic Progress**
**Innovation** Croda refocused its innovation efforts, introducing a new rigorous framework and reallocating R&D resources to prioritize customer-centric innovation.
**Customer Experience** The company improved customer experience through tailored solutions, bespoke service packages, and regionalization of claims testing and formulation support.
**Transformation Program** Crodas transformation program delivered £28 million in gross benefits in 2025, with a target of £100 million in total annualized benefits by 2028.
**Financial Framework to 2028**
Croda set out a new financial framework to 2028, targeting
**Sales Growth** 3-6% organic sales growth CAGR
**Adjusted Operating Margin** >20% by 2028
**Free Cash Flow-to-Sales Ratio** >12% by 2028
**Return on Invested Capital (ROIC)** >10% by 2028
**2026 Outlook**
For 2026Croda expects
**Group Organic Sales Growth** Within the 3-6% range
**Adjusted Operating Margin** Further increase driven by improving profitability in Consumer Care and Life Sciences
**Adjusted Operating Profit** In line with current market expectations at constant currency
**Conclusion**
Croda International PLC demonstrated resilience and progress in 2025, delivering sales growth, improved profitability, and strategic advancements despite market challenges. The companys financial framework to 2028 and 2026 outlook reflect its confidence in achieving sustainable growth, enhanced profitability, and improved returns on capital.
CRDA 14:00
Croda International PLC
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of shares under the Companys Share Incentive Plan by the SIP Trustee (Equiniti Share Plan Trustees Limited) - partnership shares purchased on behalf of PDMRs as detailed in c) and matching shares awarded to PDMRs as detailed in c).

AI Crunch

Single-Ticker AI Crunch
CRDA signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Croda International PLC. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full CRDA AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for CRDA on 2026-03-11.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
4162597888
Enterprise Value
9985694459
Public Float
90.91
Broker Target
3558.214
Shares Out
139354139
Long Interest
86
Short Interest
14
Exchange
LSE
Currency Code
GBX
ISIN
GB00BJFFLV09
Market
LSE - MAIN MARKET
Sector
Chemicals
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
1.11
Ex Divi
2026-04-09
Earnings Date
2026-02-24
Net Debt
523800000.0
Cash
172800000.0
EPS
0.44
Net Income
62000000.0
Revenue
1699400000.0
Enterprise Value
9985694459
Trailing PE
67.7727
Forward PE
17.1527
Price Sales TTM
2.4495
Price Book MRQ
1.8905
EV Revenue
2.7412
EV EBITDA
18.1828

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
12.7919
Institutions As Of
2026-04-02
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
22
Sale Director Dealing
20
Purchase TR1
4
Sale TR1
5
Broker Coverage Rows
34
Institution Holders Tracked
3
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit CRDA.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2026-03-11 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Croda International PLC has fresh news flow feeding the chart narrative.
AI Charts Studio
CRDA Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-03-11 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 11.64%
RSI Gauge
Price Change
AI Forecast